Showing results (21-30 of 467) with videos related to
Sort By:
Pageof 47
British Journal of Cancer|June 9, 1999
The sulfhydryl containing compounds WR-2721 and glutathione as radio- and chemoprotective agents. A review, indications for use and prospectsG A Hospers, E A Eisenhauer, E G de VriesThe Netherlands Journal of Medicine|January 11, 2000
Medical oncology in the next centuryE G de Vries, N H Mulder, D T SleijferMedical Oncology and Tumor Pharmacotherapy|January 1, 1988
Mechanisms of cellular resistance to cisplatinG A Hospers, N H Mulder, E G De VriesCancer Research|April 1, 1987
Multifactorial drug resistance in an adriamycin-resistant human small cell lung carcinoma cell lineJ G Zijlstra, E G de Vries, N H MulderBritish Journal of Cancer|January 1, 1990
The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell lineG A Hospers, E G de Vries, N H MulderBritish Journal of Cancer|August 1, 1992
Modulation of cis-diamminedichloroplatinum(II) resistance: a reviewH Timmer-Bosscha, N H Mulder, E G de VriesJournal of Chromatography. B, Biomedical Sciences and Applications|December 5, 2000
Clinical chemistry of serotonin and metabolitesI P Kema, E G de Vries, F A MuskietCancer Chemotherapy and Pharmacology|January 27, 2000
Lack of nephrotoxicity of new oral platinum drug JM216 in lung cancer patientsE Fokkema, E G de Vries, S Meijer, et al.Cancer|June 1, 1991
Successful long-term control of idiopathic hypereosinophilic syndrome with etoposideA J Smit, L H van Essen, E G de VriesAnti-Cancer Drugs|June 1, 1997
Fostriecin: a review of the preclinical dataR S de Jong, E G de Vries, N H MulderPageof 47